# CAR-T Therapy

China’s 'In Vivo' Breakthrough: A New Frontier in Autoimmune Disease Treatment

Chinese researchers from Shandong University have developed a breakthrough method for treating autoimmune hepatitis through in-body cell reprogramming. This 'in vivo' approach offers a more efficient alternative to traditional CAR-T therapies and signals a major shift in how autoimmune diseases may be treated globally.